AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Revolution Medicines, Inc. Director's Dealing 2021

Dec 21, 2021

30695_dirs_2021-12-21_670a6022-c820-4961-a791-a75b8284c00d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Revolution Medicines, Inc. (RVMD)
CIK: 0001628171
Period of Report: 2021-12-17

Reporting Person: Horn Margaret A (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-17	Common Stock	S	491	$24.41	Disposed	25508	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	53302	Indirect

Footnotes

F1: Held by Margaret A. Horn Revocable Living Trust.

F2: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F3: Includes 12,188 RSUs.